With the theme of "New Quality Driven and Piloting Forward", the launching ceremony of the Yangtze River Delta Biomedical New Quality Pilot List was held in the Yangtze River Delta G60 Science and Technology Innovation Corridor Biomedical Industry Base Exhibition Center recently, aiming to integrate innovation and empowerment resources, make every effort to build a world-class industrial cluster, and cultivate and develop new quality productivity.
With the help of the coordinated development of the G60 science and technology innovation corridor industry in the Yangtze River Delta, after years of development, Songjiang has nearly 3,000 enterprises related to the biomedical field, and has gathered a number of leading enterprises in subdivided fields and "specialized, special and new" enterprises such as Henlius, Haohai Biotech, Xinkaiyuan, and Huadao Biotechnology. The total industrial output value of biomedicine in the region will increase from 2.97 billion yuan in 2016 to 11.24 billion yuan in 2023.
In order to integrate innovation and empower resources and make every effort to build a world-class industrial cluster, the Yangtze River Delta G60 Science and Technology Innovation Corridor Innovation Research Center and Shanghai Yiyun Information Technology Co., Ltd. jointly carried out the selection of the Yangtze River Delta biomedical new quality pilot list. Man Yuanyuan, Head of the Innovation Cooperation Group of the G60 Joint Office and Deputy Director of the G60 Innovation Research Center, said: "Biomedicine is one of the seven major new industries that the G60 Science and Technology Innovation Corridor in the Yangtze River Delta focuses on developing. At present, the nine cities have gathered a number of high-quality biomedical industrial parks and major R&D platforms, and it is hoped that more parks and enterprises will actively participate in the selection of the Yangtze River Delta biomedical new quality pilot list, and deeply explore the cooperation space in terms of brand promotion, policy docking, and integration of industry and finance, and jointly explore a new path for the high-quality development of the biomedical industry. ”
Liu Yun, chairman of the National Biomedical Enterprise Platform and chairman of Shanghai Yiyun Information Technology Co., Ltd., introduced the Yangtze River Delta biomedical new quality pilot list plan, and explained in detail the specific plan and process arrangement of this selection activity. Liu Yun said: "This list is a comprehensive inventory of biomedical enterprises in the Yangtze River Delta, covering more than 10,000 enterprises in more than 500 characteristic parks. ”
At the ceremony, representatives of the participating companies conducted a project roadshow on behalf of Shanghai Lurui Biotechnology Co., Ltd., Shanghai Yijian Health Technology Co., Ltd., Shiyuan Medical Technology (Shanghai) Co., Ltd., and Shanghai Linyan Medical Technology Co., Ltd., introducing in detail the company's business areas, organizational structure, core team, core competitiveness, product system and other related information. After the launching ceremony, the participants also went to the G60 Biomedical Industry Base Exhibition Center and Haohai Bioscience Eye Health Production and Innovation Center for inspection and exchange.
Text: Han Haifeng
Photo: Han Haifeng Courtesy of the interviewee
Editor: Zhou Yuwei